September 12, 2019 Bio/Pharma/CRO

Roche’s Tecentriq as a first-line monotherapy helped certain people with advanced non-small cell lung cancer live longer compared with chemotherapy

Basel, 12 September 2019 Roche’s Tecentriq as a first-line monotherapy helped certain people with advanced non-small cell lung cancer live longer compared with chemotherapy Data will be shared with health authorities globally, including the US Food and Drug Administration (FDA) and European Medicines Agency (EMA)Bullet Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive data... Read more

September 2, 2019 Bio/Pharma/CRO PR/Corporate

Positive phase III results show Xofluza reduces risk of developing flu after contact with an infected person by 86%

Basel, 02 September 2019 Positive phase III results show Xofluza reduces risk of developing flu after contact with an infected person by 86% BLOCKSTONE study reaches primary endpoint of fewer people testing positive for flu, with fever and at least one respiratory symptom, when treated with Xofluza versus placebo Xofluza may represent an important and... Read more

September 2, 2019 Bio/Pharma/CRO PR/Corporate

Roche presents positive phase III study results for one-dose Xofluza in children with flu

Basel, 02 September 2019 Roche presents positive phase III study results for one-dose Xofluza in children with flu Phase III MINISTONE-2 data are consistent with known safety profile of Xofluza (baloxavir marboxil) in children and show comparable efficacy to oseltamivir Xofluza was administered as a new one-dose oral suspension, a potentially more convenient treatment option... Read more

July 31, 2019 Acad, Gov/Utilities Atomic Spectroscopy Bio/Pharma/CRO Chromatography Clinical Research/Diagn. Lab Top-10

Agilent Companion Diagnostic Gains Expanded FDA Approval in Esophageal Squamous Cell Carcinoma (ESCC)

Agilent Companion Diagnostic Gains Expanded FDA Approval in Esophageal Squamous Cell Carcinoma (ESCC) PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify ESCC patients SANTA CLARA, Calif., July 31, 2019 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s PD-L1 IHC... Read more

July 10, 2019 Bio/Pharma/CRO M&A, Partnerships

Fujifilm and Axcelead Drug Discovery Partners Begin Collaborating to Advance Drug Discovery Solutions Using iPSCs

Quick Order Contact Account View Cart (0) Log In Why FCDI Partners & Providers FCDI Customer Stories Our Technology Cellular Therapy Drug Discovery Health & Nutrition Stem Cell Banking Products & Services Cardiac Cells iCell Cardiomyocytes iCell Cardiomyocytes2 iCell Cardiomyocytes Diversity Panel MyCell Cardiomyocytes Brugada iCell Cardiomyocytes CPVT (E2311D) MyCell Cardiomyocytes DCM (L35P) MyCell Cardiomyocytes... Read more

June 26, 2019 Bio/Pharma/CRO Cell Analysis Tools Life Science Tools

Promega 2019 Corporate Responsibility Report Highlights Commitments to Environmental Sustainability, Employee Well-Being and Community Support

Madison, WI USA. (June 26, 2019) Promega Corporation, a global biotechnology manufacturer, today announced publication of its annual Corporate Responsibility Report of sustainable practices and resulting trends through the previous year. The 2019 report documents how, over the last three years, an overall culture of sustainability resulted in an 8% reduction in the company’s carbon-to-revenue footprint. “We not... Read more

June 26, 2019 Bio/Pharma/CRO Cell Analysis Tools Lab Equipment Lab Top-10 Liq. Handling & Robotics Product Launch

New-Generation Incubator Brings the Latest Technology to Mid-Capacity Microplate Cell Culture

New-Generation Incubator Brings the Latest Technology to Mid-Capacity Microplate Cell Culture New Thermo Scientific Cytomat 2 C-LiN Series Automated Incubator delivers robust and reliable culture solution for cell-based pharmaceutical applications BARCELONA, Spain – SLAS EUROPE 2019 – (June 26, 2019) – As the pharmaceutical industry continues to increase its focus on the development of biologics,... Read more

June 18, 2019 Bio/Pharma/CRO

Sartorius starts up operations at expanded site in Puerto Rico

Göttingen, Germany | Yauco, Puerto Rico – June 18, 2019 Investment of more than 100 million U.S. dollars Area designed for future growth After investing more than 100 million U.S. dollars, Sartorius, a leading international partner of biopharmaceutical research and the industry, started up its expanded manufacturing operations in Yauco, Puerto Rico. The U.S. market is... Read more

June 18, 2019 Bio/Pharma/CRO Lab Top-10

New State-of-the-Art Facility Increases Agilent’s Capacity to Produce Nucleic Acid-Based Therapeutics

New facility in Frederick, Colorado, to produce high-quality molecules with the potential to treat cancer and other diseases SANTA CLARA, Calif., June 18, 2019 Agilent Technologies Inc. (NYSE: A) today announced the opening of a production facility in Colorado that more than doubles its capacity to develop and manufacture “oligos,” which are short DNA and... Read more